Impact of New Genomic Technologies on Understanding Adverse Drug Reactions.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Works matching IS 03125963 AND DT 2016 AND VI 55 AND IP 4
Results: 8
1
2
Erratum to: Impact of New Genomic Technologies on Understanding Adverse Drug Reactions.
- Published in:
- 2016
- By:
- Publication type:
- corrected article
3
Population Pharmacokinetic Analysis of Lanreotide Autogel/Depot in the Treatment of Neuroendocrine Tumors: Pooled Analysis of Four Clinical Trials.
- Published in:
- 2016
- By:
- Publication type:
- journal article
4
Pharmacokinetics, Efficacy, and Safety of the Preservative-free Fixed Combination of Tafluprost 0.0015% and Timolol 0.5% in Healthy Volunteers: A Phase I Comparison vs. the Corresponding Preservative-free Monotherapies.
- Published in:
- 2016
- By:
- Publication type:
- journal article
5
Predicting the Effect of CYP3A Inducers on the Pharmacokinetics of Substrate Drugs Using Physiologically Based Pharmacokinetic (PBPK) Modeling: An Analysis of PBPK Submissions to the US FDA.
- Published in:
- 2016
- By:
- Publication type:
- journal article
6
The Effect of Nizatidine, a MATE2K Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin in Healthy Volunteers.
- Published in:
- 2016
- By:
- Publication type:
- journal article
7
The First-in-Class Potassium-Competitive Acid Blocker, Vonoprazan Fumarate: Pharmacokinetic and Pharmacodynamic Considerations.
- Published in:
- 2016
- By:
- Publication type:
- journal article
8
Therapeutic Concentrations of Metformin: A Systematic Review.
- Published in:
- 2016
- By:
- Publication type:
- journal article